These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 36880183)
1. Induced Pluripotent Stem Cells in the Era of Precise Genome Editing. Punetha M; Saini S; Chaudhary S; Yadav PS; Whitworth K; Green J; Kumar D; Kues WA Curr Stem Cell Res Ther; 2024; 19(3):307-315. PubMed ID: 36880183 [TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells. Kim EJ; Kang KH; Ju JH Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282 [TBL] [Abstract][Full Text] [Related]
3. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system. Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152 [TBL] [Abstract][Full Text] [Related]
4. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system. Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575 [TBL] [Abstract][Full Text] [Related]
9. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
10. Site-Specific Genome Engineering in Human Pluripotent Stem Cells. Merkert S; Martin U Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935 [TBL] [Abstract][Full Text] [Related]
11. Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells. Molugu K; Khajanchi N; Lazzarotto CR; Tsai SQ; Saha K CRISPR J; 2023 Oct; 6(5):473-485. PubMed ID: 37676985 [TBL] [Abstract][Full Text] [Related]
14. Precision genome editing in the CRISPR era. Salsman J; Dellaire G Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771 [TBL] [Abstract][Full Text] [Related]
15. Targeted mutagenesis in human iPSCs using CRISPR genome-editing tools. Long Y; Cech TR Methods; 2021 Jul; 191():44-58. PubMed ID: 33444739 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Genome Editing and In Vivo Delivery. Ramirez-Phillips AC; Liu D AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099 [TBL] [Abstract][Full Text] [Related]
17. Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders. Chen Y; Wen R; Yang Z; Chen Z Gene Ther; 2022 May; 29(5):207-216. PubMed ID: 33750926 [TBL] [Abstract][Full Text] [Related]
18. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy. Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410 [TBL] [Abstract][Full Text] [Related]
19. [CRISPR/Cas9 technology in disease research and therapy: a review]. Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436 [TBL] [Abstract][Full Text] [Related]
20. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells. Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]